TMPO promotes cellular dissemination and metastasis in circulating tumor cells

Metastasis-the process by which cancer cells spread beyond the primary tumor to distant organs-accounts for the vast majority of cancer-related deaths. To elucidate mechanisms underlying dissemination and metastasis in prostate cancer, we have investigated circulating tumor cells (CTCs) obtained from genetically engineered mouse models (GEMMs). The phenotypic and molecular properties of the CTCs, and organoids derived from these CTCs, closely model the tumor and metastatic phenotypes of their parental GEMMs. Moreover, organoids derived from individual CTCs exhibit molecular and morphological heterogeneity that is associated with distinct metabolic states as well as differences in human prostate cancer outcome. Using computational systems analyses, we have identified <i>TMPO</i> , encoding the nuclear membrane protein lamina-associated polypeptide 2 (Lap2), as a key driver of this heterogeneity. <i>TMPO</i> activity is upregulated in advanced human prostate tumors, metastases, and CTCs, and is associated with adverse clinical outcome. Our findings indicate that <i>TMPO</i> promotes dissemination and metastasis <i>in vivo</i> by enhancing survival in conditions of metabolic stress, and reveal a novel mechanistic link between CTC heterogeneity, stress adaptation, and metastatic potential.

Authors

Institutions

Publication Details

Journal
bioRxiv (Cold Spring Harbor Laboratory)
Published
2025-12-27
DOI
https://doi.org/10.64898/2025.12.27.696673
Primary Topic
Cancer Cells and Metastasis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

TMPO promotes cellular dissemination and metastasis in circulating tumor cells

Aunika Zheng, Matteo Di Bernardo, David T. Miyamoto, Hermenegildo Garcı́a et al.
bioRxiv (Cold Spring Harbor Laboratory)
Cancer Cells and Metastasis
article

TMPO promotes cellular dissemination and metastasis in circulating tumor cells

Aunika Zheng, Matteo Di Bernardo, David T. Miyamoto, Hermenegildo Garcı́a, Stephanie N. Afari, Florencia Picech, Giuseppe Nicolò Fanelli, Michael M. Shen, Shyamala Maheswaran, B Robinson, Aleksandar Obradović, Cory Abate‐Shen, Jaime Y. Kim, Andrea Califano, Renu K. Virk, Caroline Laplaca, Juan Martín Arriaga, Peter A. Sims, Paraskevi Giannakakou, H. Henry Guo, Alexander Chui, Jung Seung Nam, Min Zou, Jinqiu Lu, Tian Zheng, Soonbum Park, Scott T. Tagawa, Massimo Loda, Christine Iok In Chio, Francisca Nunes de Almeida, David M. Nanus, Arianna Giacobbe, Carlos Pedraz-Valdunciel, Maya Stella Dixon, Daniel A. Harber
article en

Abstract

Metastasis-the process by which cancer cells spread beyond the primary tumor to distant organs-accounts for the vast majority of cancer-related deaths. To elucidate mechanisms underlying dissemination and metastasis in prostate cancer, we have investigated circulating tumor cells (CTCs) obtained from genetically engineered mouse models (GEMMs). The phenotypic and molecular properties of the CTCs, and organoids derived from these CTCs, closely model the tumor and metastatic phenotypes of their parental GEMMs. Moreover, organoids derived from individual CTCs exhibit molecular and morphological heterogeneity that is associated with distinct metabolic states as well as differences in human prostate cancer outcome. Using computational systems analyses, we have identified <i>TMPO</i> , encoding the nuclear membrane protein lamina-associated polypeptide 2 (Lap2), as a key driver of this heterogeneity. <i>TMPO</i> activity is upregulated in advanced human prostate tumors, metastases, and CTCs, and is associated with adverse clinical outcome. Our findings indicate that <i>TMPO</i> promotes dissemination and metastasis <i>in vivo</i> by enhancing survival in conditions of metabolic stress, and reveal a novel mechanistic link between CTC heterogeneity, stress adaptation, and metastatic potential.

bioRxiv (Cold Spring Harbor Laboratory)
Howard Hughes Medical Institute (US), Harvard University (US), Cornell University (US), Massachusetts General Hospital (US), Center for Cancer Research (US), Weill Cornell Medicine (US), Columbia University (US)
Good health and well-being
Openalex Percentile: Top 30%
Cancer Cells and Metastasis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.